— Know what they know.
Not Investment Advice

TMCI NASDAQ

Treace Medical Concepts, Inc.
1W: +18.3% 1M: +38.1% 3M: +47.0% YTD: +8.8% 1Y: -59.5% 3Y: -89.2% 5Y: -91.2%
$2.82
+0.10 (+3.68%)
After Hours: $2.79 (-0.03, -1.24%)
Weekly Expected Move ±14.0%
$2 $2 $3 $3 $3
NASDAQ · Healthcare · Medical - Devices · Alpha Radar Buy · Power 64 · $176.5M mcap · 48M float · 1.77% daily turnover · Short 46% of daily vol
Smart Money Score
Moderate 50
Insider+$0.4M
Congress
ETF Holdings
Key Statistics
Market Cap$176.5M
52W Range1.17-7.78
Volume836,148
Avg Volume852,924
Beta1.11
Dividend
Analyst Ratings
2 Buy 6 Hold 1 Sell
Consensus Hold
Company Info
CEOJohn T. Treace
Employees477
SectorHealthcare
IndustryMedical - Devices
IPO Date2021-04-23
Websitetreace.com
203 Fort Wade Road
Ponte Vedra, FL 32081
US
904 373 5940
About Treace Medical Concepts, Inc.

Treace Medical Concepts, Inc., an orthopedic medical device company, engages in the design, manufacture, and marketing of medical devices for foot and ankle surgeons in the United States. It offers Lapiplasty procedure that allows podiatric surgeons to treat all three dimensions of the bunion, providing patients with a cosmetic and medical improvement. The company also provides Lapiplasty Mini-Incision precision system. In addition, it offers products to address ancillary surgical procedures, including akin osteotomies, weil osteotomies, intercuneiform stabilization, lesser tarsometatarsal joint fusions, and autograft bone harvesting, as well as for MTP fusion. Treace Medical Concepts, Inc. was founded in 2013 and is headquartered in Ponte Vedra Beach, Florida.

Recent Insider Trades

NameTypeSharesPriceDate
BAKEWELL JOHN K A-Award 30,000 2026-05-19
Kiernan Jane E A-Award 30,000 2026-05-19
Berry Lance A A-Award 30,000 2026-05-19
Jain Deepti A-Award 30,000 2026-05-19
HAMILTON LAWRENCE W A-Award 30,000 2026-05-19

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms